Re-operations for early postoperative complications after CRS and HIPEC: indication, timing, procedure, and outcome
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
http://link.springer.com/content/pdf/10.1007/s00423-019-01808-8.pdf
Reference27 articles.
1. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29–42
2. Sugarbaker PH (2003) Peritonectomy procedures. Surg Oncol Clin N Am 12(3):703–727 xiii
3. Stewart JH, Shen P, Levine EA (2005) Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 12(10):765–777. https://doi.org/10.1245/ASO.2005.12.001
4. Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249(6):900–907
5. Baratti D, Kusamura S, Mingrone E, Balestra MR, Laterza B, Deraco M (2012) Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg 256(2):334–341. https://doi.org/10.1097/SLA.0b013e31825704e3
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Doxorubicin as Risk Factor for Fascial Dehiscence After CRS-HIPEC for Peritoneal Metastases;Anticancer Research;2024-03-27
2. Abdominal Surgery: Colorectal Surgery Including Peritonectomy;Side Effects of Cancer Therapy;2023-10-25
3. Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis;Cancers;2022-11-25
4. Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond;Frontiers in Oncology;2022-11-08
5. Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer;European Journal of Surgical Oncology;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3